Italian biomedical firm Esaote of Genoa reported 1998 financial results last month, boasting consolidated net sales of $201.2 million, up 25% from 1997's $161.1 million. Esaote's increased net sales include revenues from ultrasound firm Pie Medical,
Italian biomedical firm Esaote of Genoa reported 1998 financial results last month, boasting consolidated net sales of $201.2 million, up 25% from 1997's $161.1 million. Esaote's increased net sales include revenues from ultrasound firm Pie Medical, which Esaote bought from Philips Medical Systems last year (SCAN 4/29/98). Esaote also posted robust international sales of $121.5 million, up 42% from $85.5 million in 1997. The company's international revenues accounted for 60% of its total sales.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.